Minerva Neurosciences
NERV
78 hedge funds and large institutions have $290M invested in Minerva Neurosciences in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 6 closing their positions.
200% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 6
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
16% more funds holding
Funds holding: 67 → 78 (+11)
8.88% more ownership
Funds ownership: 0% → 8.88% (+8.9%)
0% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 23
15% less capital invested
Capital invested by funds: $343M → $290M (-$52.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$7.19M |
| 2 |
NC
Nexthera Capital
New York
|
+$6.29M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$1.56M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$965K |
| 5 |
Norges Bank
Oslo,
Norway
|
+$911K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$4.09M |
| 2 |
IHM
Iguana Healthcare Management
New York
|
-$3.83M |
| 3 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$2.33M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.07M |
| 5 |
Renaissance Technologies
New York
|
-$1.94M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Group One Trading
Chicago,
Illinois
| $11K | -$1.23K | -12 | -10% |
|
77
BlackRock
New York
| $11K | – | – | – |
|
|
BIM
78
Bogle Investment Management
Newton Lower Falls,
Massachusetts
| – | -$2.07M | -18,330 | Closed |
|
|
DCM
79
DAFNA Capital Management
Los Angeles,
California
| – | -$467K | -4,138 | Closed |
|
|
SSA
80
Schonfeld Strategic Advisors
New York
| – | -$289K | -2,560 | Closed |
|
|
AL
81
Airain Ltd
St. Peter Port,
Guernsey
| – | -$244K | -2,161 | Closed |
|
|
PPA
82
Parametric Portfolio Associates
Seattle,
Washington
| – | -$200K | -1,773 | Closed |
|
|
AIM
83
Acrospire Investment Management
Chicago,
Illinois
| – | -$71K | -630 | Closed |
|
84
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$306 | +3 | New |
|
NERV Hedge Fund Activity: Q4 2016 in Review
78 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2016, worth a combined $290M — down 15% from $343M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new NERV positions and 6 closed out — a net gain of 12 holders — while 23 added to existing stakes and 23 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $7.19M. The largest seller was Millennium Management, cutting an estimated $4.09M.
- 78 institutional investors held Minerva Neurosciences (NERV) as of Q4 2016, up from 67 in Q3 2016.
- Funds reported $290M of Minerva Neurosciences stock for Q4 2016, down 15% quarter-over-quarter.
- 18 funds opened new Minerva Neurosciences positions in Q4 2016 and 6 closed out, a net change of +12 holders.
- The largest Minerva Neurosciences buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $7.19M added.
- The largest Minerva Neurosciences seller in Q4 2016 was Millennium Management, an estimated $4.09M sold.
Based on aggregated 13F filings for Q4 2016.